bendamustine hydrochloride has been researched along with Carcinoma, Epidermoid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bathe, K; Bottke, D; Hinkelbein, W; Wiegel, T | 1 |
Adamietz, IA; Bormeth, SB; Böttcher, HD; Mose, S; Rahn, AN; Schilcher, RB | 1 |
1 trial(s) available for bendamustine hydrochloride and Carcinoma, Epidermoid
Article | Year |
---|---|
Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck.
Topics: Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Otorhinolaryngologic Neoplasms | 2007 |
1 other study(ies) available for bendamustine hydrochloride and Carcinoma, Epidermoid
Article | Year |
---|---|
[Palliative radiochemotherapy with Bendamustin for advanced recurrent head and neck tumors].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nitrogen Mustard Compounds; Palliative Care; Radiotherapy Dosage; Radiotherapy, Adjuvant; Treatment Outcome | 2001 |